Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimary Health Regulatory News (PHP)

Share Price Information for Primary Health (PHP)

Share Price is delayed by 15 minutes
Get Live Data
90.30    -0.95 (-1.04%)
Bid:
90.50
Ask:
90.60
Spread: 0.10 (0.11%)
Market Cap: £2.34b
PHP Live PriceLast checked at - London Stock Exchange

Intraday Primary Health Share Chart

Rule 2.9 Announcement

16 Jul 2025 17:58

RNS Number : 3809R
Primary Health Properties PLC
16 July 2025
Ā 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

For immediate release

16 July 2025

Rule 2.9 Announcement

Ā 

Further to the announcement made in accordance with Rule 2.9 of the City Code on Takeovers and Mergers (the "Code") by Primary Health Properties PLC ("PHP" or the "Company") on 12 March 2025, PHP is updating its disclosure in relation to Rule 2.9 of the Code.

On 15 July 2025, PHP repaid its £150 million 2.875% Guaranteed Convertible Bonds (the "Convertible Bonds") issued by the Company's wholly owned subsidiary PHP Finance (Jersey No.2) Limited ("PHP Jersey"). Therefore, PHP's only remaining class of security for the purposes of Rule 2.9 of the Code is its ordinary shares. PHP confirms that, as at the date of this announcement, it has 1,336,493,786 ordinary shares of 12.5p ("PHP Ordinary Shares") each in issue and admitted to trading on the London Stock Exchange. The International Securities Identification Number for the PHP Ordinary Shares is GB00BYRJ5J14 and the LEI number is 213800Y5CJHXOATK7X11.

Enquiries:

Primary Health Properties PLC

Harry Hyman, Non-Executive Chair

Mark Davies, Chief Executive Officer

Richard Howell, Chief Financial Officer

Ā 

+44 (0) 7970 246 725

via Sodali & Co

Rothschild & Co (Joint Lead Financial Adviser to PHP)

Alex Midgen

Sam Green

Nikhil Walia

Jake Shackleford

Ā 

+44 (0) 207 280 5000

Deutsche Numis (Joint Lead Financial Adviser and Joint Broker to PHP)

Kevin Cruickshank

Heraclis Economides

Stuart Ord

Ben Stoop

Jack McLaren

Ā 

+44 (0) 207 260 1000

Sodali & Co (Communications for PHP)

Rory Godson

Elly Williamson

Louisa Henry

Ā 

+44 (0) 7970 246 725

CMS Cameron McKenna Nabarro Olswang LLP is acting as legal adviser to PHP.

Further information

N.M. Rothschild & Sons Limited ("Rothschild & Co"), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively as joint lead financial adviser to PHP and for no one else in connection with the subject matter of this Announcement and will not be responsible to anyone other than PHP for providing the protections afforded to its clients or for providing advice in connection with the subject matter of this Announcement. Neither Rothschild & Co nor any of its affiliates (nor any of their respective directors, officers, employees or agents), owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Rothschild & Co in connection with this Announcement, any statement contained herein or otherwise.

Numis Securities Limited ("Deutsche Numis"), which is authorised and regulated in the United Kingdom by the FCA in the United Kingdom, is acting exclusively as joint lead financial adviser to PHP and for no one else in connection with the subject matter of this Announcement and will not be responsible to anyone other than PHP for providing the protections afforded to its clients or for providing advice in connection with the subject matter of this Announcement. Neither Deutsche Numis nor any of its affiliates (nor any of their respective directors, officers, employees or agents), owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Deutsche Numis in connection with this Announcement, any statement contained herein or otherwise.

This announcement is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote in any jurisdiction.

The release, publication or distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe such restrictions. Any failure to comply with such restrictions may constitute a violation of the securities law of any such jurisdiction.

Disclosure requirements of the Code

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
RTTUNVNRVNUBAAR
Date   Source Headline
1st Jun 20267:00 amRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSDirector/PDMR Shareholding
29th Apr 20261:30 pmRNSResults of AGM voting
29th Apr 20267:00 amRNSAGM Trading Update
20th Apr 20262:00 pmRNSBoard directorships
25th Mar 20261:00 pmRNSIssue of shares for Long Term Incentive Plan
25th Mar 20267:00 amRNSAnnual Report 2025 and Notice of 2026 AGM
17th Mar 20267:00 amRNSPreliminary Results
17th Mar 20267:00 amRNSPreliminary Results
16th Mar 20261:00 pmRNSDirector/PDMR Shareholding
16th Mar 20261:00 pmRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSNotice of Preliminary Results
11th Mar 20268:30 amRNSNotice of Interim Dividend
26th Jan 202612:30 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSTrading update & notice of interim dividend
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
2nd Dec 20257:00 amRNSDirector Appointment
24th Nov 202511:00 amRNSDirector/PDMR Shareholding
29th Oct 20257:15 amRNSAcquisition of Assura plc – CMA Phase 1 Clearance
24th Oct 20252:00 pmRNSAGM – Voting Results Update Statement
20th Oct 20258:00 amRNSAdmission of New PHP Shares
17th Oct 202511:25 amRNSAdmission of New PHP Shares
15th Oct 20253:30 pmRNSCompletion of Squeeze-out Procedure
8th Oct 202512:34 pmRNSForm 8.3 -Primary Health Properties PLC
6th Oct 20258:45 amRNSCancellation of LSE Listing
3rd Oct 20251:18 pmRNSForm 8.3 - Primary Health Properties PLC
2nd Oct 202512:29 pmRNSForm 8.3 - Primary Health Properties PLC
1st Oct 202512:19 pmRNSForm 8.3 - Primary Health Properties PLC
23rd Sep 20254:00 pmRNSDirector/PDMR Shareholding
22nd Sep 20251:30 pmRNSForm 8.3 - Primary Health Properties PLC
22nd Sep 20257:00 amRNSNotice of Interim Dividend
19th Sep 20253:00 pmRNSDirector/PDMR Shareholding
15th Sep 202512:44 pmRNSForm 8.3 - Primary Health Properties PLC
12th Sep 20258:00 amRNSAdmission of New PHP Shares
11th Sep 20251:30 pmRNSApplication for Admission of New PHP Shares
11th Sep 202510:00 amRNSHolding(s) in Company
9th Sep 20252:21 pmRNSForm 8.3 -Primary Health Properties PLC
8th Sep 20253:30 pmRNSDirector/PDMR Shareholding
5th Sep 20251:53 pmRNSForm 8.3 - Primary Health Properties PLC
4th Sep 202510:00 amRNSHolding(s) in Company
4th Sep 20258:00 amRNSAdmission of New PHP Shares
3rd Sep 20253:00 pmRNSDirector/PDMR Shareholding
3rd Sep 20252:21 pmRNSAdmission of New PHP Shares
3rd Sep 20252:13 pmRNSForm 8.3 - Primary Health Properties PLC.
1st Sep 20254:30 pmRNSHolding(s) in Company
1st Sep 20252:59 pmRNSForm 8.3 - Primary Health Properties PLC
29th Aug 20251:08 pmRNSForm 8.3 - Primary health properties
28th Aug 20251:44 pmRNSForm 8.3 - Primary Health property
28th Aug 20251:40 pmRNSForm 8.3 - Assura Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.